Record quarterly revenue and profits were driven by broad-based growth across key practices, with Life Sciences, Energy, and Antitrust & Competition Economics leading. Raised full-year guidance reflects strong demand, robust pipeline, and continued investments in talent.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.